Chemistry:FG5865

From HandWiki

FG5865 is from the diphenylbutylpiperazine class of agents. It is a 5-HT1A agonist and a 5-HT2A antagonist.[1]

It is believed to be an anxiolytic agent with treatment in substance abuse disorders particularly alcoholism.[2][3]

There is evidence to suggest that FG5865 is a SNDRI.[4]

See also

References

  1. "New drugs for the treatment of experimental alcoholism". Alcohol (Fayetteville, N.Y.) 11 (6): 439–451. 1994. doi:10.1016/0741-8329(94)90064-7. PMID 7865140. 
  2. "5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo". European Journal of Pharmacology 238 (2–3): 357–367. July 1993. doi:10.1016/0014-2999(93)90867-H. PMID 7691622. 
  3. "Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist". Pharmacology Biochemistry and Behavior 53 (1): 33–40. January 1996. doi:10.1016/0091-3057(95)00195-6. PMID 8848457. 
  4. "Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro". European Journal of Pharmacology 282 (1–3): 131–135. August 1995. doi:10.1016/0014-2999(95)00300-A. PMID 7498267.